Digene corporation

Pharmacogenomics

Volumn 5, Issue 1, 2004, Pages 129-132

  Obiso, Richard ^a   Lorincz, Attila ^a  

^a NONE   (United States)

Author keywords

Chlamydia; Gonorrhea; Human papillomavirus; Hybrid capture technology; Molecular diagnostics; Women's health

Indexed keywords

VIRUS DNA;

ARTICLE; ASSAY; CANCER; CANCER SCREENING; CHLAMYDIA; CYTOMEGALOVIRUS; DIAGNOSTIC TEST; DNA DETERMINATION; GENDER; GENE TECHNOLOGY; GENETIC SCREENING; GONORRHEA; HEALTH CARE INDUSTRY; HEPATITIS B VIRUS; HUMAN; INFECTION; MARKETING; MEDICAL RESEARCH; MOLECULAR BIOLOGY; PATENT; PATIENT CARE; PATIENT MONITORING; SEXUALLY TRANSMITTED DISEASE; STANDARD; UNITED STATES; UTERINE CERVIX CANCER; WART VIRUS;

DNA; DRUG INDUSTRY; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; INFECTION; NEOPLASMS; REAGENT KITS, DIAGNOSTIC;

CANCER VIRUS; CHLAMYDIA; CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0347766089     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/phgs.5.1.129.25678     Document Type: Article

References (2)

1. ACOG Committee on Practice Bulletins: ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet. Gynecol. 102(2), 417-427 (2003).
2. Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J. Clin. 53(1), 27-43 (2003).